Source: International Journal of Clinical Pharmacy. Unidade: FMRP
Subjects: FÁRMACOS ANTIRREUMÁTICOS, ARTRITE REUMATOIDE, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMIDES, Ana Paula Monteiro et al. Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis. International Journal of Clinical Pharmacy, v. 43, n. 3, p. 737-742, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11096-020-01171-5. Acesso em: 11 set. 2024.APA
Gomides, A. P. M., Albuquerque, C. P. de, Santos, A. B. V., Bértolo, M. B., Louzada Júnior, P., Giorgi, R. D. N., et al. (2021). Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis. International Journal of Clinical Pharmacy, 43( 3), 737-742. doi:10.1007/s11096-020-01171-5NLM
Gomides APM, Albuquerque CP de, Santos ABV, Bértolo MB, Louzada Júnior P, Giorgi RDN, Radominski SC, Guimarães MFBR, Bonfiglioli KR, Sauma M de FL da C, Pereira IA, Brenol CV, Mota LMH da, Pinheiro G da RC. Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis [Internet]. International Journal of Clinical Pharmacy. 2021 ; 43( 3): 737-742.[citado 2024 set. 11 ] Available from: https://doi.org/10.1007/s11096-020-01171-5Vancouver
Gomides APM, Albuquerque CP de, Santos ABV, Bértolo MB, Louzada Júnior P, Giorgi RDN, Radominski SC, Guimarães MFBR, Bonfiglioli KR, Sauma M de FL da C, Pereira IA, Brenol CV, Mota LMH da, Pinheiro G da RC. Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis [Internet]. International Journal of Clinical Pharmacy. 2021 ; 43( 3): 737-742.[citado 2024 set. 11 ] Available from: https://doi.org/10.1007/s11096-020-01171-5